Pictet-Health -P USD

Reference Data

ISIN LU0188501257
Valor Number 1812187
Bloomberg Global ID BBG000Q3KYF1
Fund Name Pictet-Health -P USD
Fund Provider Pictet Asset Management S.A. Genève, Switzerland
Phone: +41 58 323 10 24
www.assetmanagement.pictet
Fund Provider Pictet Asset Management S.A.
Representative in Switzerland Pictet Asset Management S.A.
Genève 73
Phone: +41 58 323 30 00
Distributor(s) Credit Suisse AG
Zürich
Phone: +41 44 333 11 11 UBS AG
Zürich
Phone: +41 44 234 11 11 Vontobel Fonds Services AG
Zürich
Phone: +41 58 283 74 77
Asset Class Equities
EFC Category Equity Health Care
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel)
Investment Strategy *** To increase the value of your investment while seeking to achieve a positive social impact. The Fund applies a sustainable strategy and invests mainly in equities or similar securities issued by companies that are active in sectors related to health. To safeguard the future of the world’s health services, better prevention and more effective treatments are necessary. These companies help to stem health care costs growth and maximize productivity. The Fund applies a sustainable strategy and invests mainly in equities or similar securities issued by companies that are active in sectors related to health. To safeguard the future of the world’s health services, better prevention and more effective treatments are necessary. These companies help to stem health care costs growth and maximize productivity.
Peculiarities

Fund Prices

Current Price * 323.92 USD 17.04.2025
Previous Price * 324.52 USD 16.04.2025
52 Week High * 375.43 USD 07.02.2025
52 Week Low * 304.33 USD 07.04.2025
NAV * 323.92 USD 17.04.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 464,142,921
Unit/Share Assets *** 35,900,449
Trading Information SIX

Performance

YTD Performance -7.50% 31.12.2024
17.04.2025
YTD Performance (in CHF) -17.14% 31.12.2024
17.04.2025
1 month -6.47% 17.03.2025
17.04.2025
3 months -9.91% 17.01.2025
17.04.2025
6 months -10.75% 17.10.2024
17.04.2025
1 year -4.68% 17.04.2024
17.04.2025
2 years -1.42% 17.04.2023
17.04.2025
3 years -5.94% 19.04.2022
17.04.2025
5 years +13.63% 17.04.2020
17.04.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI 1.1106
ADDI Date 17.04.2025

Top 10 Holdings ***

Boston Scientific Corp 7.30%
Eli Lilly and Co 5.54%
Intuitive Surgical Inc 5.04%
Lonza Group Ltd 4.59%
UnitedHealth Group Inc 4.24%
Garmin Ltd 4.20%
Steris PLC 3.71%
AstraZeneca PLC 3.68%
Novo Nordisk AS Class B 3.58%
Agilent Technologies Inc 3.49%
Last data update 31.03.2025

Cost / Risk

TER *** 2.011%
TER date *** 30.09.2024
Performance Fee ***
PTR
Max. Management Fee *** 2.40%
Ongoing Charges *** 2.01%
SRRI ***
SRRI date *** 31.03.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)